Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
Autor: | Prashanth Thevkar, Siddhartha Yavvari, Nethaji Muniraj, Sahithi Sukhavasi, Monish Ram Makena, Himavanth R. Gatla |
---|---|
Rok vydání: | 2019 |
Předmět: |
human diseases
Chemokine Antineoplastic Agents chemokines Inflammation Review Histone Deacetylases Catalysis lcsh:Chemistry Inorganic Chemistry HDAC inhibitors Neoplasms Gene expression Animals Humans Medicine Physical and Theoretical Chemistry Effector functions lcsh:QH301-705.5 Molecular Biology Spectroscopy Histone Acetyltransferases biology business.industry Organic Chemistry HDACs General Medicine cytokines Computer Science Applications Chromatin Histone Deacetylase Inhibitors Histone lcsh:Biology (General) lcsh:QD1-999 biology.protein Cancer research medicine.symptom business After treatment |
Zdroj: | International Journal of Molecular Sciences, Vol 20, Iss 5, p 1110 (2019) International Journal of Molecular Sciences |
ISSN: | 1422-0067 |
DOI: | 10.3390/ijms20051110 |
Popis: | Histone acetyltransferases (HATs) and histone deacetylases (HDACs) counteract with each other to regulate gene expression by altering chromatin structure. Aberrant HDAC activity was reported in many human diseases including wide range of cancers, viral infections, cardiovascular complications, auto-immune diseases and kidney diseases. HDAC inhibitors are small molecules designed to block the malignant activity of HDACs. Chemokines and cytokines control inflammation, immunological and other key biological processes and are shown to be involved in various malignancies. Various HDACs and HDAC inhibitors were reported to regulate chemokines and cytokines. Even though HDAC inhibitors have remarkable anti-tumor activity in hematological cancers, they are not effective in treating many diseases and many patients relapse after treatment. However, the role of HDACs and cytokines in regulating these diseases still remain unclear. Therefore, understanding exact mechanisms and effector functions of HDACs are urgently needed to selectively inhibit them and to establish better a platform to combat various malignancies. In this review, we address regulation of chemokines and cytokines by HDACs and HDAC inhibitors and update on HDAC inhibitors in human diseases. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |